{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:55:19Z","timestamp":1794099319650,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32DK126381"],"award-info":[{"award-number":["F32DK126381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK130870"],"award-info":[{"award-number":["R01DK130870"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013711","name":"Bayer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.xkme.2022.100465","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:55:56Z","timestamp":1649386556000},"page":"100465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0118-7909","authenticated-orcid":false,"given":"Jonathan G.","family":"Amatruda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Ivey-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xkme.2022.100465_bib1","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.xkme.2022.100465_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","article-title":"Decongestion in acute heart failure","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246","article-title":"Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure","volume":"6","author":"Kociol","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr Heart Fail Rep"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.xkme.2022.100465_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.xkme.2022.100465_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.xkme.2022.100465_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/clpt.2013.135","article-title":"Renin-angiotensin-aldosterone system inhibitors in heart failure","volume":"94","author":"Shearer","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xkme.2022.100465_bib9","doi-asserted-by":"crossref","first-page":"F1115","DOI":"10.1152\/ajprenal.00337.2002","article-title":"Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100465_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002333","article-title":"Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure","volume":"9","author":"Kula","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.xkme.2022.100465_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.xkme.2022.100465_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/M18-3285","article-title":"High-dose spironolactone when patients with acute decompensated heart failure are resistant to loop diuretics: a pilot study","volume":"171","author":"Bansal","year":"2019","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.xkme.2022.100465_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical renin-angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr Physiol"},{"issue":"4","key":"10.1016\/j.xkme.2022.100465_bib14","first-page":"183","article-title":"Molecular and pathophysiological features of angiotensinogen: a mini review","volume":"4","author":"Wu","year":"2011","journal-title":"N\u00a0Am J Med Sci (Boston)"},{"issue":"1","key":"10.1016\/j.xkme.2022.100465_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jcp.29889","article-title":"The emerging role of angiotensinogen in cardiovascular diseases","volume":"236","author":"Xu","year":"2021","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.xkme.2022.100465_bib16","series-title":"Clinical Physiology of Acid-Base and Electrolyte Disorders","author":"Rose","year":"2001"},{"issue":"9","key":"10.1016\/j.xkme.2022.100465_bib17","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/ndt\/gfz123","article-title":"The renin-angiotensin-aldosterone system update: full-court press","volume":"35","author":"Provenzano","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2022.100465_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2215\/CJN.11600918","article-title":"Serum and urine albumin and response to loop diuretics in heart failure","volume":"14","author":"Charokopos","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2022.100465_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ejhf.757","article-title":"Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure","volume":"19","author":"ter Maaten","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.xkme.2022.100465_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-3758(97)00040-2","article-title":"Optimal locally robust M-estimates of regression","volume":"64","author":"Yohai","year":"1997","journal-title":"J\u00a0Stat Plan Inference"},{"issue":"11","key":"10.1016\/j.xkme.2022.100465_bib23","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory distal reabsorption drives diuretic resistance in human heart failure","volume":"28","author":"Rao","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.xkme.2022.100465_bib24","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.xkme.2022.100465_bib25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100465_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000669","article-title":"Regulation of renal pendrin activity by aldosterone","volume":"30","author":"Bourgeois","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"10.1016\/j.xkme.2022.100465_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.V1271335","article-title":"Loop diuretic infusion increases thiazide-sensitive Na(+)\/Cl(-)-cotransporter abundance: role of aldosterone","volume":"12","author":"Abdallah","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2022.100465_bib28","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.xkme.2022.100465_bib29","first-page":"1097","article-title":"Spironolactone in acute heart failure patients with renal dysfunction and risk factors for diuretic resistance: from the ATHENA-HF trial","volume":"35","author":"Greene","year":"2019","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.xkme.2022.100465_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ejhf.1802","article-title":"Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial","volume":"22","author":"de Denus","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.xkme.2022.100465_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ehf2.12634","article-title":"Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure","volume":"7","author":"Kobayashi","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"16","key":"10.1016\/j.xkme.2022.100465_bib32","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/ijms20163886","article-title":"Normalizing plasma renin activity in experimental dilated cardiomyopathy: effects on edema, cachexia, and survival","volume":"20","author":"Sullivan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"25","key":"10.1016\/j.xkme.2022.100465_bib33","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/CIRCULATIONAHA.108.767202","article-title":"Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans","volume":"117","author":"Fisher","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.xkme.2022.100465_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCHEARTFAILURE.107.740704","article-title":"Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure","volume":"1","author":"McMurray","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"16","key":"10.1016\/j.xkme.2022.100465_bib35","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","article-title":"Aliskiren, enalapril, or aliskiren and enalapril in heart failure","volume":"374","author":"McMurray","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.xkme.2022.100465_bib36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.xkme.2022.100465_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ejhf.973","article-title":"Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial","volume":"20","author":"Vaduganathan","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1172\/JCI114454","article-title":"In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system","volume":"85","author":"Ingelfinger","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xkme.2022.100465_bib39","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1172\/JCI116020","article-title":"Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure","volume":"90","author":"Schunkert","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.xkme.2022.100465_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/cvr\/27.5.731","article-title":"Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat","volume":"27","author":"Schunkert","year":"1993","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1523-1755.2002.00155.x","article-title":"Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production","volume":"61","author":"Kobori","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2022.100465_bib42","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10157-018-1567-1","article-title":"Independent regulation of renin-angiotensin-aldosterone system in the kidney","volume":"22","author":"Nishiyama","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.xkme.2022.100465_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2014.10.031","article-title":"Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?","volume":"443","author":"Emdin","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"9","key":"10.1016\/j.xkme.2022.100465_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2022.100465_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2459\/JCM.0000000000000156","article-title":"Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism","volume":"16","author":"Vergaro","year":"2015","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"issue":"2","key":"10.1016\/j.xkme.2022.100465_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchf.2014.10.005","article-title":"Renin-angiotensin-aldosterone system activation during decongestion in acute heart failure: friend or foe?","volume":"3","author":"Verbrugge","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.xkme.2022.100465_bib47","series-title":"Brenner and Rector\u2019s The Kidney","year":"2020"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:24:30Z","timestamp":1762910670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059522000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2590059522000784"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100465","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}],"article-number":"100465"}}